BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioSimilar

China to Position Taizhou as a famous Chinese Medical City

It will build a platform for international exchanges and cooperation in the pharmaceutical and general health industries to further gather innovative...

November 05, 2021 | News

Eisai and FUJI YAKUHIN will provide new treatment options for hyperuricemia and gout in Five ASEAN Countries

Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD. announced today that they have concluded a license agreement concerning dotinurad (generic name), a treatment fo...

August 31, 2021 | News

Enzene Biosciences Ltd. obtains a Marketing Authorization for its Denosumab Biosimilar drug in India

Osteoporosis is a commonly occurring condition associated with advanced age, and is frequently caused by oestrogen decline in post-menopausal women. It can...

August 29, 2021 | News

Bottmedical enters the market with innovative braces

Bottmedical has developed clear braces made from bio-based polymers, further details of which can be found in an article&...

July 29, 2021 | News

Cytiva and Pall to expand manufacturing capacity and services across geographies

Major investments are expanding manufacturing capacity for life sciences products at 13 Cytiva and Pall Corporation sites helping to meet customer demand. ...

July 27, 2021 | News

Biocon Biologics to Manufacture and Commercialize a Broadly Neutralizing Antibody for India and Select Emerging Markets

Biocon Biologics Ltd., a fully integrated biosimilars company and a subsidiary of Biocon Ltd. , announced today that U.S. based Adagio Therapeutics has gra...

July 26, 2021 | News

Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%

Biocon Ltd , an innovation-led global biopharmaceuticals company, announced its consolidated financial results for the first quarter ended June ...

July 26, 2021 | News

Intas, First Indian company to launch a biosimilar product in the EU

Intas Pharmaceuticals Ltd continues to pledge their commitment to increasing access to high quality medicines by entering into an exclusive license agreeme...

July 22, 2021 | News

Thermo Fisher Scientific Expands Hematology Oncology NGS Portfolio

Thermo Fisher Scientific today announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant cl...

July 20, 2021 | News

Konyang University Hospital in South Korea relies on Molecular Health's MH Guide for personalized cancer medicine

It makes Konyang University Hospital the first facility in South Korea to use MH Guide. "Precision medicine in cancer care enables personalized treat...

July 16, 2021 | News

Alvotech initiates clinical studies for AVT04, a proposed biosimilar to Stelara

Alvotech, today, announced that the first patient has been dosed in the comparative, confirmatory efficacy and safety clinical study (AVT04-GL-301) for AVT...

July 06, 2021 | News

Innovent Biologics Announces the Approval of Pemazyre® (pemigatinib) in Taiwan Market

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medi...

June 22, 2021 | News

MSD Announces Supply Agreement with U.S. Govt. for Molnupiravir

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced it has entered into a procurement agreement with&...

June 21, 2021 | News

CARsgen Therapeutics officially listing on HKEX

CARsgen Therapeutics Holdings Limited (the "Company", stock code: 2171.HK) today announced that the Company's Shares have been traded on the Main Board of ...

June 19, 2021 | News

Stay Connected